Adjunct professor < Adjuvant < Adjuvant approach

Facettes : Author.f AffOrg.f AffPays.f AffRegion.f AffVille.f Teeft.f

List of bibliographic references

Number of relevant bibliographic references: 27.
[0-20] [0 - 20][0 - 27][20-26][20-40]

Ident.	Authors (with country if any)	Title
000285 (2013)		Vaccination against H1N1 looks safer than influenza during pregnancy
000381 (2013)		Poster Abstracts
000413 (2013)	V. Vamsee Aditya Mallajosyula [Inde] ; Michael Citron ; Xianghan Lu ; Jan Ter Meulen ; Raghavan Varadarajan [Inde] ; Xiaoping Liang [Inde]	In vitro and in vivo characterization of designed immunogens derived from the CD‐helix of the stem of influenza hemagglutinin
000813 (2012)	Marie-Françoise Klucker [France] ; François Dalençon [France] ; Patricia Probeck [France] ; Jean Haensler [France]	AF03, an alternative squalene emulsion‐based vaccine adjuvant prepared by a phase inversion temperature method
000987 (2011)	Alexander K. Andrianov [États-Unis] ; Daniel P. Decollibus [États-Unis] ; Alexander Marin [États-Unis] ; Ashley Webb [États-Unis] ; Yolanda Griffin [États-Unis] ; Richard J. Webby [États-Unis]	PCPP‐formulated H5N1 influenza vaccine displays improved stability and dose‐sparing effect in lethal challenge studies
000994 (2011)	John Goulding [États-Unis] ; Vikas Tahiliani [États-Unis] ; Shahram Salek-Ardakani [États-Unis]	OX40:OX40L axis: emerging targets for improving poxvirus‐based CD8+ T‐cell vaccines against respiratory viruses
000A34 (2011)	Philip R. Dormitzer [États-Unis] ; Grazia Galli [États-Unis] ; Flora Castellino [États-Unis] ; Hana Golding [États-Unis] ; Surender Khurana [États-Unis] ; Giuseppe Del Giudice [États-Unis] ; Rino Rappuoli [États-Unis]	Influenza vaccine immunology
000B91 (2010)	Claire S. Waddington [Royaume-Uni] ; W T Walker ; C. Oeser ; A. Reiner [Royaume-Uni] ; T. John [Royaume-Uni] ; S. Wilkins ; M. Casey ; P E Eccleston ; R J Allen ; I. Okike ; S. Ladhani ; E. Sheasby ; K. Hoschler ; N. Andrews ; P. Waight ; A C Collinson ; P T Heath ; A. Finn ; S N Faust ; M D Snape [Royaume-Uni] ; E. Miller ; A J Pollard [Royaume-Uni]	Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study
000C68 (2010)	Marc-André D Oust ; Manon M. Couture ; Nathalie Charland ; Sonia Trépanier ; Nathalie Landry ; Frédéric Ors ; Louis-P. Vézina	The production of hemagglutinin‐based virus‐like particles in plants: a rapid, efficient and safe response to pandemic influenza
000D39 (2010)		Poster Presentations
000E01 (2010)	Daisuke Ikeno ; Kazuhiko Kimachi ; Yoichiro Kino ; Seiichi Harada ; Kayo Yoshida ; Shinji Tochihara ; Shigeyuki Itamura ; Takato Odagiri ; Masato Tashiro ; Kenji Okada ; Chiaki Miyazaki ; Kohji Ueda [Japon]	Immunogenicity of an inactivated adjuvanted whole‐virion influenza A (H5N1, NIBRG‐14) vaccine administered by intramuscular or subcutaneous injection
001140 (2009)	Yuri Ghendon [Russie] ; Stanislav Markushin [Russie] ; Yuri Vasiliev [Russie] ; Irina Akopova [Russie] ; Irina Koptiaeva [Russie] ; Georgy Krivtsov [Russie] ; Olga Borisova [Russie] ; Nelly Ahmatova [Russie] ; Ekaterina Kurbatova [Russie] ; Svetlana Mazurina [Russie] ; Valentina Gervazieva [Russie]	Evaluation of properties of chitosan as an adjuvant for inactivated influenza vaccines administered parenterally
001203 (2009)		30th Annual Meeting of the Society for Medical Decision Making Abstracts
001263 (2008)	Gary T. Jennings [Suisse] ; Martin F. Bachmann [Suisse]	The coming of age of virus-like particle vaccines
001303 (2008)	M. Keith Howard [Autriche] ; Otfried Kistner [Autriche] ; P. Noel Barrett [Autriche]	Pre-clinical development of cell culture (Vero)-derived H5N1 pandemic vaccines
001314 (2008)		Paper Session Ethics & Quality of Life
001427 (2008)		29TH ANNUAL MEETING OF THE SOCIETY FOR MEDICAL DECISION MAKING
001479 (2007)		The 2nd Congress of Asian Society for Pediatric Research
001514 (2007)	Takeshi Ichinohe [Japon] ; Noriyo Nagata [Japon] ; Peter Strong [Royaume-Uni] ; Shin-Ichi Tamura [Japon] ; Hidehiro Takahashi [Japon] ; Ai Ninomiya [Japon] ; Masaki Imai [Japon] ; Takato Odagiri [Japon] ; Masato Tashiro [Japon] ; Hirofumi Sawa [Japon] ; Joe Chiba [Japon] ; Takeshi Kurata [Japon] ; Tetsutaro Sata [Japon] ; Hideki Hasegawa [Japon]	Prophylactic effects of chitin microparticles on highly pathogenic H5N1 influenza virus
001798 (2006)	Frank M. Orson [États-Unis] ; Berma M. Kinsey [États-Unis] ; Charles L. Densmore [États-Unis] ; Tina Nguyen [États-Unis] ; Yan Wu [États-Unis] ; Innocent N. Mbawuike [États-Unis] ; Philip R. Wyde [États-Unis]	Protection against influenza infection by cytokine‐enhanced aerosol genetic immunization
001C47 (2001)	Stanley A. Plotkin	Vaccines in the 21st Century

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i -k "Adjuvant" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i  \
                -Sk "Adjuvant" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Adjuvant
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021